Share this link via:
Global Single Cell Analysis Market size is estimated at USD 4.65 billion in 2024, and is expected to reach USD 8.63 billion by 2032, growing at a CAGR of 13.11% during the forecast period (2024-2032).
The reasons for this expansion are the increasing use of sequencing technology in drug research and disease diagnosis, its profitable expansion, developments in single-cell analysis and cell isolation technologies, and the increasing prevalence of cancer.
High-speed technological development has facilitated one to study the transcriptome and genome of an individual cell in depth. Single-cell analyses show different cell types to have different activities and ancestries, which determine each cell's reaction to alterations in the physiology of the host environment. Single-cell technology facilitates molecular route & process characterization as well as cellular heterogeneity measurement. Single-cell sequencing is advancing very fast, applied in immunology and oncology as well as a host of other uses. There are 22 phase-II clinical trials involving single-cell sequencing technology listed on Clinicaltrials.gov.
Single-cell analysis is required in precision medicine, where the treatment is customized according to the individual's unique characteristics. Clinicians can choose the best treatment for a patient based on profound insight into the cellular heterogeneity of a disease like cancer. A new study released in April of 2024 claims that researchers created an easy method to sort head and neck squamous cell cancer (HNSCC) based on B cells with single-cell analytical tools. The result of this trial will allow researchers to know how patients will do and react to immunotherapy. In addition, single-cell analysis enables scientists to understand how different cell types of the same tissue or organ react differently to medicines.
The market has grown exponentially with the lucrative and speedy advancement of sequencing technology. Understanding the intricacies of biology is now more and more dependent on single-cell analysis, an approach that measures the genomic, transcriptomic, proteomic, and metabolomic profiles of single cells. Thousands to millions of single cells can now be examined in a single experiment with much higher throughput using the available sequencing technology. This scale has provided access to new research findings and diagnostics, facilitating the development of the industry.
The advance in single-cell analysis and cell isolation technology has driven the expansion of the market. The sensitivity and resolution of single-cell analysis have been improved by new technologies, and low-abundance chemicals and rare cell types can be detected. Technical advancement has enlarged the scope of application for single-cell analysis and isolation; these include medicinal development, clinical diagnostics, and basic research. Also, cell biology research is applied in the incorporation of artificial intelligence in single-cell research. For example, NVIDIA and Deepcell, Inc. partnered in January 2024 to drive the application of generative artificial intelligence in single-cell research.
The market scope is segmented because of by Product, by Application, by Workflow.
Based on the Product of the market is segmented into Consumables, Instruments.
In 2023, the consumables segment commanded the largest revenue share of 55.1%, therefore leading the market. Market growth can be contributed to by the requirement for increased accuracy and extensive cellular analysis in research and clinical diagnostics, along with the increased demand for personalized medicine and biotechnology advances. Single-cell analysis consumables' market comprises several types of goods manufactured to simplify studying individual cells. These include materials like reagents, kits, microplates, and other tools used to undertake thorough analyses of single-cell behaviours, gene expression, and other important aspects of cell biology.
During the forecast period, the instruments segment is anticipated to grow at a significant CAGR. Patient assessment effectiveness has been enhanced by the application of smart technology, which has raised demand for single-cell technologies such as PCR and NGS. Moreover, the creation of integrated devices—such as laboratory equipment and in-patient monitoring and management devices—is enabling effective evaluation and administration of research labs and clinical trials, which is expected to fuel market growth.
Based on the Application of the market is segmented into Cancer Immunology, Neurology, Stem cell, Non-invasive prenatal diagnosis, In-vitro fertilization Others.
The cancer segment held the majority share of 31.8% in 2023 and was thus the market leader. The growth potential of these technologies to have a substantial impact on cancer diagnosis and treatment makes this segment the leading growth driver. Single-cell analysis has been demonstrated to be useful for cancer cell diagnosis. These methods make it simple to ascertain genetic diversity in cell types, mutation rates, and cell growth conditions.
During the forecast period, the immunology segment will grow at the fastest pace. Scientists are able to describe comprehensively immune cell population heterogeneity as a result of single-cell analysis technologies. By investigating gene expression, epigenetic control, and protein expression at the single-cell level, scientists’ study molecular mechanisms underlying immune cell fate decisions, for instance, T-cell lineage commitment or B-cell differentiation. Moreover, single-cell analysis methods should investigate how the immune system reacts to different stimuli such as infection, vaccines, and cancer.
By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA are provided by the study. As per the latest analyses, the single-cell analysis market globally is dominated by North America. Its advanced research facilities, huge investments in the pharmaceutical and biotechnology sectors, and the presence of leading technological companies are the primary reasons for its dominance. The region's dominance is also supplemented by the high price of healthcare and the strong support offered for research and development. Single-cell technology innovation is largely propelled by the sheer number of academic and research organizations in the United States and Canada, with the latter's favourable research environment also playing a role.
The market of single-cell analysis is expected to grow at the fastest pace in Asia-Pacific. Huge R&D investments, increased healthcare expenses, and the rapid advancement of biotechnology in countries such as China, Japan, and India are the primary reasons for this growth. The area is expanding due to its augmented emphasis on individualised medicine and drug development coupled with enhanced investment by the public and private sector. The growth of the market in Asia-Pacific is also being fuelled by the proliferation of state-of-the-art research facilities and increased awareness of the clinical diagnostic applications of single-cell analysis.
In February 2024, as a move to diversify its products of single-cell technology, 10X Genomics recently introduced the launch of GEM-X, which are two single-cell gene assays namely Chromium Single Cell Immune Profiling 5'v3 and Chromium Single Cell Gene Expression 3'v4.
In February 2024, Takara Bio USA, Inc. launched two single-cell solutions, the Shasta Whole-Genome Amplification Kit and the Shasta Total RNA-Seq Kit.
In February 2024 Ann Arbour, USA-based Singleron Biotechnologies launched its laboratories. The company had aimed to deliver complete solutions starting from tissue dissociation to single-cell multi-omic analysis, automation instruments, single-cell reagent kits, and bioinformatics service.
In January 2024, Hamilton Ink, a robot development company, and BD announced an agreement that would support developing automated solutions to the requirements for single cell multiomics studies.
In January 2024, at the UK Festival of Genomics conference, Singleron Biotechnologies launched the AccuraSCOPE Single Cell Transcriptome and Genome Library Kit. In its exclusive capability to profile the whole genome and the transcriptome in parallel, the kit offers researchers a precious tool for studying.
The report will cover the qualitative and quantitative data on the Global Single Cell Analysis Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.
Study Period | 2024-32 |
Base Year | 2023 |
Estimated Forecast Year | 2024-32 |
Growth Rate | CAGR of 13.11% from 2024 to 2032 |
Segmentation | By Product, By Application, By Workflow, By End-use, By Region |
Unit | USD Billion |
By Product |
|
By Application |
|
By Workflow |
|
By End-use |
|
By Region |
|
North America accounted for the highest xx% market share in terms of revenue in the Single-Cell Analysis market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Single-Cell Analysis. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Single-Cell Analysis companies in economies such as Japan and China.
The objective of the report is to present comprehensive analysis of Global Single-Cell Analysis Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.
Single-Cell Analysis Market Report is also available for below Regions and Country Please Ask for that
You'll get the sample you asked for by email. Remember to check your spam folder as well. If you have any further questions or require additional assistance, feel free to let us know via-
+1 724 648 0810 +91 976 407 9503 sales@intellectualmarketinsights.com
20 Mar 2023
Intellectual Market Insights Research © 2026. All rights reserved.
